The dynamic nature of the K-Ras/calmodulin complex can be altered by oncogenic mutations

Related Experiment Video

Updated: Oct 26, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.2K

Hazem Abdelkarim1, Nicholas Leschinsky1, Hyunbum Jang2

  • 1Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL, 60607, USA.

Current Opinion in Structural Biology
|July 26, 2021
PubMed

Insights

Oncogenic mutant K-Ras protein interactions are key in cancer. New research reveals how K-Ras binds with calmodulin, influencing cancer cell functions and offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Structural Biology

Background:

  • Oncogenic mutant K-Ras drives cancer progression by forming signaling complexes.
  • The precise roles of K-Ras mutations in these complexes remain unclear.
  • Understanding K-Ras interactions is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To review recent advances in the specific binding between K-Ras and calmodulin.
  • To explore the functional and structural implications of this interaction in cancer.
  • To highlight the significance of K-Ras/calmodulin dynamics for novel therapeutic strategies.

Main Methods:

  • Literature review of recent studies on K-Ras and calmodulin interactions.
  • Analysis of structural data on K-Ras conformational states.
  • Synthesis of findings on the regulatory roles of calmodulin in K-Ras signaling.

Main Results:

  • The interaction between K-Ras and calmodulin dynamically regulates cancer cell functions.
  • Structural data indicate K-Ras adopts multiple conformations, affecting its binding partners.
  • K-Ras/calmodulin complex formation is flexible and context-dependent.

Conclusions:

  • Understanding the K-Ras/calmodulin interaction is essential for deciphering K-Ras signaling in cancer.
  • Targeting K-Ras and its partners, like calmodulin, presents a promising avenue for cancer treatment.
  • Further structural and functional studies are needed to fully exploit these interactions therapeutically.

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

8.9K
Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells09:20

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells

Published on: July 6, 2021

2.6K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.6K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.7K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K